Jericho Sciences
Jericho Sciences, LLC is focused on research and development of novel antiviral therapeutic and diagnostic products. Thier lead candidate compound exerts action via a viral peptide motif shared by many types of viruses, including human immunodeficiency virus (HIV-1) and feline immunodeficiency virus (FIV). While current combination antiretroviral therapy (cART) regimens can minimize disease progression by reducing viral loads for HIV-infected individuals, they do not address challenges posed by persistent viral reservoirs, therapeutically elusive physiological compartments and the development of drug resistance. New therapeutic agents useful to reduce persistent and elusive virus represent the next evolution for HIV treatment. Jericho Sciences collaborates with academic, government and industrial researchers and maintains a strong intellectual property position for all portfolio projects.
Tech Stack (14 technologies)
Frequently Asked Questions
What technologies does Jericho Sciences use?+
Jericho Sciences uses 14 technologies including Colorlib Shapely, Contact Form 7, OWL Carousel.
What industry is Jericho Sciences in?+
Jericho Sciences operates in the Biotechnology industry.
Where is Jericho Sciences based?+
Jericho Sciences is headquartered in United States.
Explore More
Need this data at scale?
Get ready-to-use datasets: companies, technologies, and tech adoption signals across 3M+ websites.
Browse DatasetsData last updated: June 2026